Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $136.85 | Total: $684.25 |
| 1 | 10 | $115.92 | Total: $1,159.20 |
| 1 | 25 | $98.21 | Total: $2,455.25 |
| 1 | 50 | $83.72 | Total: $4,186.00 |
| 1 | 100 | $72.45 | Total: $7,245.00 |
Overview
Atuzabrutinib (SAR 444727) is a selective Bruton's tyrosine kinase (Btk) inhibitor that inhibits intra-neutrophilic neutrophilic granulocytes through inhibition of the adhesion receptor signaling pathway, and can be used to study autoimmune disorders such as arthritis in rheumatoid rodents and pemphigus vulgaris.
Chemical Properties
| Molecular Formula | C30H30FN7O2 |
| Molecular Weight | 539.6 |
| CAS Numbers | 1581714-49-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | NC1=C2C(N(N=C2C3=C(F)C=C(OC4=CC=CC=C4)C=C3)[C@H]5CN(C(C(=CC(C)(C)C)C#N)=O)CCC5)=NC=N1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Steven GOURLAY, et al. Treatment of pemphigus. WO2016100914A1.